DAFNA Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,716	Closed	-$1.28M	–	81
2025 Q3	$1.28M	Sell	80,716 -49,600	-38%	-$733K	0.32%	55
2025 Q2	$1.74M	Hold	130,316	–	–	0.48%	40
2025 Q1	$1.33M	Hold	130,316	–	–	0.38%	47
2024 Q4	$2.06M	Buy	130,316 +56,562	+77%	+$2.94M	0.52%	37
2024 Q3	$4.28M	Buy	73,754 +6,000	+9%	+$296K	1.01%	26
2024 Q2	$3.1M	Hold	67,754	–	–	0.74%	34
2024 Q1	$4.49M	Sell	67,754 -6,607	-9%	-$392K	1.02%	29
2023 Q4	$2.96M	Buy	74,361 +8,400	+13%	+$263K	0.71%	37
2023 Q3	$2.1M	Buy	65,961 +18,300	+38%	+$683K	0.65%	39
2023 Q2	$1.92M	Buy	47,661 +28,300	+146%	+$1.24M	0.52%	42
2023 Q1	$827K	Sell	19,361 -13,639	-41%	-$689K	0.25%	50
2022 Q4	$1.58M	Sell	33,000 -6,000	-15%	-$280K	0.45%	49
2022 Q3	$1.47M	Hold	39,000	–	–	0.39%	49
2022 Q2	$1.08M	Buy	+39,000	New	+$1.71M	0.29%	61